FDA Diversity Advisory Plan D.A.P. Let's DAP It Up: Inspiring Change, Advancing Diversity
The panel discussion will cover the importance of the FDA Diversity Advisory Plan (D.A.P) in driving positive change within the clinical research industry. By promoting diversity, equity, and inclusion, D.A.P aims to create a more inclusive healthcare landscape that benefits patients, professionals, and society at large. The panelists will share insights, experiences, and commitment to diversity that will inspire and motivate the audience to actively contribute to advancing these essential goals.